Amsulostat

AssetAlso SNT-5505, PXS-5505

Inhibits lysyl oxidase family enzymes to prevent collagen cross-linking and fibrosis.

Stage: Phase 2
Modality: Small molecule
Target: LOX; 1
Indication: 0
Trials: 1
Developer

Indications

1

Myelofibrosis
Phase 2, syntaratx.com.au, 7 Oct 2026

In the full profile

Targets and what it contains5
Owner and partners1
Evidence for its targets1
Competitors1

Every asset’s record: target, stage, trials and the evidence behind it.

Updated 7 Oct 2026, 1 source